Skip to main content
Fig. 1 | BMC Endocrine Disorders

Fig. 1

From: A giant invasive macroprolactinoma with recurrent nasal bleeding as the first clinical presentation: case report and review of literature

Fig. 1

Pituitary enhanced magnetic resonance imaging (MRI) showing tumor shrinkage after treatment with a dopamine agonist in the young patient with a macroprolactinoma. MRI scans obtained before dopamine agonist therapy, showing a large pituitary mass in coronary, sagittal and axial station (A1, B1 and C1, respectively) and after 1 year of treatment, with marked reduction of the mass (A2, B2 and C2, respectively). Before treatment with bromocriptine, an irregular mass about 7.8 cm × 4.6 cm × 5.0 cm was observed on the saddle. It invades the sphenoid and cavernous sinuses, with encasement of the carotid arteries and optic chiasm compression

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us